25th Anniversary of IJMS: Updates and Advances in Molecular Oncology
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 26
Special Issue Editor
Interests: colorectal cancer; tumor-immmune interactions; cancer genetics and epigenetics; immunotherapy; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer research entered a new molecular era at the turn of the 21st century: the full sequence of the human genome was just published, and genomic sequencing became standard practice and is now even part of routine clinical diagnostics. Today, as we celebrate the journal’s 25th anniversary, we reflect not only on its growth and accomplishments but also on the remarkable journey of cancer research, which the journal has documented and helped shape. Our understanding of cancer biology has deepened from single-gene models to complex networks involving epigenetics, tumour heterogeneity, the tumour microenvironment, and interactions with the immune system. This has led to whole new cancer treatment options and improved diagnostics, all leading to much better prospects for current cancer patients.
This anniversary Special Issue intends to bring together a collection of articles that reflect on the journal’s legacy while highlighting key advances that are currently redefining the field. We invite long-standing leaders and emerging voices, all of whom share a commitment to rigorous science and translational impact, to contribute to this special issue. Together, these pieces provide both a retrospective lens and a forward-looking perspective on the challenges and opportunities that lie ahead of us.
Among the highlights of this issue are reviews and original studies covering diverse and pressing topics: the evolving role of precision oncology, the promise and limitations of liquid biopsy technologies, advances in cancer immunotherapy, the rise of AI and digital pathology, and novel insights into the molecular mechanisms of tumour development. Each contribution will be selected not only for its scientific merit but also for its relevance to the journal’s mission of connecting the bench and bedside.
We also recognize that the future of molecular oncology demands continued collaboration across disciplines, sectors, and continents. As cancer remains one of the most complex and urgent health challenges of our time, the integration of molecular insights with clinical practice remains as critical today as it was 25 years ago. With this in mind, Molecular Oncology will continue to serve as a platform for work that not only advances knowledge but also catalyses real-world progress.
We invite you to contribute to this Special Issue, reflect on the progress we have made together, and join us in shaping the next 25 years of molecular oncology all for our shared pursuit of better cancer care.
Dr. Peter J. K. Kuppen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular oncology
- cancer epigenetics
- tumour heterogeneity
- tumour microenvironment
- precision oncology
- liquid biopsy
- cancer immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
